Profile data is unavailable for this security.
About the company
Modular Medical, Inc. is a development stage, medical device company. The Company is focused on the design, development, and commercialization of an insulin pump using modernized technology to increase pump adoption in the diabetes marketplace. The Company, through the creation of two-part patch pump, MODD1, seeks to serve both the type 1 and type 2 diabetes markets. The Company, using its methods of insulin measurement, is able to eschew complex mechanisms and instead build a product candidate using only parts from high volume consumer electronics manufacturing lines. It provides an insulin pump, which has both basal (steady flow) and bolus (mealtime dosing) insulin disbursement. It also consists of a natural migration path to multi-chamber/multi-liquid pumps, potentially offering an array of new therapies to patients with diabetes and other conditions.
- Revenue in USD (TTM)0.00
- Net income in USD-16.76m
- Incorporated1998
- Employees37.00
- LocationModular Medical Inc16772 WEST BERNARDO DRIVESAN DIEGO 92127United StatesUSA
- Phone+1 (858) 800-3500
- Fax+1 (775) 786-6755
- Websitehttps://www.modular-medical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cidara Therapeutics Inc | 46.38m | -36.47m | 51.14m | 69.00 | -- | -- | -- | 1.10 | -8.07 | -8.07 | 10.26 | -3.90 | 0.6899 | -- | 2.80 | 672,144.90 | -54.24 | -65.23 | -218.59 | -154.37 | 76.93 | -- | -78.63 | -100.61 | 0.6047 | -- | -- | -- | -0.8425 | -- | 31.72 | -- | 23.33 | -- |
| Moolec Science SA | 2.65m | -52.66m | 51.37m | 45.00 | -- | 5.07 | -- | 19.42 | -1.44 | -1.44 | 0.0766 | 0.2367 | -- | -- | -- | 58,780.00 | -- | -- | -- | -- | 2.92 | -- | -1,990.79 | -- | 0.2243 | -0.1889 | 0.2372 | -- | -- | -- | -1,044.02 | -- | -- | -- |
| America Great Health | 219.13k | -859.20k | 52.78m | 7.00 | -- | -- | -- | 240.88 | -0.00004 | -0.00004 | 0.00001 | -0.0002 | 0.6746 | 0.0721 | 18.16 | 31,304.29 | -265.62 | -543.96 | -- | -- | 95.92 | -247.36 | -393.74 | -1,193.55 | 0.035 | -1.37 | -- | -- | 95.23 | -- | 84.35 | -- | -- | -- |
| Rockwell Medical Inc | 86.62m | -8.42m | 53.51m | 237.00 | -- | -- | -- | 0.6177 | -0.3584 | -0.3584 | 3.33 | -- | -- | -- | -- | 365,485.20 | -- | -46.29 | -- | -65.38 | 10.59 | 4.66 | -9.72 | -36.51 | -- | -3.41 | -- | -- | 14.84 | 5.69 | 54.82 | -- | 76.21 | -- |
| Aligos Therapeutics Inc | 13.79m | -99.59m | 53.78m | 67.00 | -- | 0.9069 | -- | 3.90 | -1.51 | -1.51 | 0.1796 | 0.7592 | 0.1105 | -- | -- | 208,969.70 | -79.78 | -51.20 | -98.27 | -59.73 | -- | -- | -722.06 | -1,399.21 | -- | -- | 0.0037 | -- | 11.66 | -- | 8.71 | -- | -62.36 | -- |
| Modular Medical Inc | 0.00 | -16.76m | 54.85m | 37.00 | -- | 9.80 | -- | -- | -0.9653 | -0.9653 | 0.00 | 0.1805 | 0.00 | -- | -- | 0.00 | -224.40 | -168.16 | -262.22 | -209.51 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 25.51 | -- | 154.53 | -- |
| Equillium Inc | 37.89m | -12.13m | 55.00m | 44.00 | -- | 2.61 | -- | 1.45 | -0.3476 | -0.3476 | 1.08 | 0.5983 | 0.6568 | -- | 8.95 | 861,227.30 | -21.02 | -46.81 | -39.66 | -57.36 | -- | -- | -32.01 | -328.35 | -- | -- | 0.00 | -- | 128.97 | -- | 78.64 | -- | 7.48 | -- |
| Kezar Life Sciences Inc | 7.00m | -101.87m | 55.74m | 58.00 | -- | 0.2971 | -- | 7.96 | -1.40 | -1.40 | 0.0965 | 2.58 | 0.0269 | -- | -- | 120,689.70 | -39.12 | -32.54 | -41.41 | -34.09 | -- | -- | -1,455.29 | -4,308.11 | -- | -- | 0.051 | -- | -- | -- | -49.28 | -- | 10.08 | -- |
| Enzo Biochem Inc | 32.80m | -23.31m | 55.84m | 179.00 | -- | 0.7776 | -- | 1.70 | -0.4699 | 0.6708 | 0.6586 | 1.40 | 0.3738 | 1.61 | 4.10 | 183,257.00 | -26.56 | -12.21 | -39.50 | -15.79 | 42.17 | 37.09 | -71.07 | -18.76 | 2.89 | -- | 0.0476 | -- | -4.85 | -21.01 | -23.02 | -- | 7.89 | -- |
| Reneo Pharmaceuticals Inc | 0.00 | -70.71m | 58.49m | 8.00 | -- | 0.7199 | -- | -- | -2.17 | -2.17 | 0.00 | 2.43 | 0.00 | -- | -- | 0.00 | -77.06 | -- | -83.08 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -48.95 | -- | -- | -- |
| Calcimedica Inc | 0.00 | -14.94m | 58.53m | 14.00 | -- | 3.39 | -- | -- | -2.64 | -2.64 | 0.00 | 1.61 | 0.00 | -- | -- | 0.00 | -48.34 | -63.99 | -66.59 | -72.71 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 3.51 | -- | -44.35 | -- |
| Carisma Therapeutics Inc | 15.07m | -81.22m | 58.58m | 107.00 | -- | 5.38 | -- | 3.89 | -2.01 | -2.01 | 0.3723 | 0.2623 | 0.1311 | -- | -- | 140,869.20 | -70.64 | -30.87 | -83.17 | -34.47 | -- | -- | -538.81 | -255.66 | -- | -- | 0.1717 | -- | -62.70 | -- | -336.93 | -- | 255.27 | -- |
| Global Pharmatech Inc. | 3.18m | -2.24m | 59.28m | 217.00 | -- | 0.4376 | -- | 18.65 | -0.0964 | -0.0964 | 0.1367 | 0.3428 | 0.2292 | 1.59 | 3.57 | 14,649.77 | -16.44 | -- | -22.55 | -- | 46.21 | -- | -71.75 | -- | 1.62 | -9.87 | 0.2223 | -- | 32.43 | -- | -142.03 | -- | -- | -- |
| Anebulo Pharmaceuticals Inc | 0.00 | -10.49m | 59.64m | 2.00 | -- | 9.19 | -- | -- | -0.4087 | -0.4087 | 0.00 | 0.2502 | 0.00 | -- | -- | 0.00 | -86.04 | -- | -95.37 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -71.89 | -- | -- | -- |
Data as of May 20 2024. Currency figures normalised to Modular Medical Inc's reporting currency: US Dollar USD
42.45%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Manchester Management Co. LLCas of 16 Feb 2024 | 3.59m | 11.60% |
| Solas Capital Management LLCas of 31 Mar 2024 | 1.89m | 6.10% |
| 683 Capital Management LLCas of 31 Mar 2024 | 1.55m | 4.99% |
| Sio Capital Management LLCas of 31 Mar 2024 | 1.54m | 4.97% |
| SilverArc Capital Management LLCas of 31 Mar 2024 | 900.00k | 2.90% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 892.64k | 2.88% |
| Bard Associates, Inc.as of 31 Mar 2024 | 824.00k | 2.66% |
| AWM Investment Co., Inc.as of 31 Mar 2024 | 750.00k | 2.42% |
| Bleichroeder LPas of 31 Mar 2024 | 700.00k | 2.26% |
| Corsair Capital Management LPas of 31 Mar 2024 | 520.24k | 1.68% |
More ▼
Data from 31 Mar 2024 - 09 May 2024Source: FactSet Research Systems Inc.
